Andrew S. Kitzmiller - 21 Feb 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role
EVP & CFO
Signature
/s/ Andrew S. Kitzmiller
Issuer symbol
N/A
Transactions as of
21 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 13:07:53 UTC
Previous filing
04 Jan 2022
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Award $0 +7,500 $0.000000 7,500 21 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Options (Right to Buy) Award $0 +5,000 $0.000000 5,000 21 Feb 2022 Common Stock 5,000 $24.74 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the RSUs awarded vest on February 21, 2023; and (ii) the remaining 75% of the RSUs awarded vest in three equal installments on each of November 4, 2023, November 4, 2024 and November 4, 2025.
F2 These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on February 21, 2023; and (ii) the remaining 75% of the options awarded vest pro rata on the 4th of each month beginning March 4, 2023 and ending November 4, 2025.